Placeholder text

Go to cart

The Promise of Low Dose Naltrexone Therapy

By Samantha Wilkinson

The Promise of Low Dose Naltrexone Therapy Medicine

The Promise of Low Dose Naltrexone Therapy

Only 1 item left in stock
Description
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
Product details
Binding:
Paperback
Edition:
illustrated
Number of Pages:
224
Release Date:
2008-11-01
Publication Date:
2008-12-01
Publisher:
McFarland
Languages:
Original: English
ISBN10:
0786437154
ISBN13:
9780786437153
GPSR Manufacturer Reference:
[email protected]
Minimum Reading Age:
18
Weight:
332 g
Height:
152 cm
Width:
229 cm
Thickness:
13 cm
Buy on Amazon

Condition

Show more

Show less
Good
The items bear minimal signs of past use, such as light scratches or memories in the form of markings. These signs of wear give the items a charming character and tell stories of their previous owners, while not affecting their functionality.
Available immediately
€8,49

Incl. VAT, plus shipping costs

PayPal
Visa
Mastercard
American Express
Only 1 item left in stock

Verified second-hand article

Verified second-hand item

Free shipping from 19€

€8,49